NuVasive (NSDQ:NUVA) said today it launched three new products as part of its biologics portfolio, including its Traditional Bone Allograft, Amniotic Membrate DS and Propel DBM …The San Diego-based company’s Traditional Bone Allograft includes cancellous chips, demineralized cancellous chips, cortical cancellous chips and cancellous crushed, which the company claims the has osteoconductive properties intended to provide a scaffold for bone growth … The newly launched Amniotic Membrane DS is a dual-sided layer of human amniotic membrane intended to act as a biologic barrier to prevent adhesions and reduce scar tissue formation near adjacent muscle, nerve and fascia layer tissues … read more